Vetr Upgrade's REGN's On Price Growth Following Positive Guidance By: Benzinga via Benzinga May 19, 2017 at 07:28 AM EDT The Vetr crowd upgraded its rating for Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) from 1 star (Strong Sell), issued three days ago, ... Read More >> Related Stocks: Regeneron Pharmaceuticals